Informed outsiders doubling down
NO
on the Q4 2016 call
2016-08-17
B
The model's full reasoning — Q4 2016 call → NO我们根据提供的财报电话会议记录,判断管理层是否报告了知情方(如现有大客户、战略合作伙伴、内部人士或完成尽职调查的成熟投资者)最近做出了重大的新财务或资源承诺,并将其作为业务轨迹的验证,而这些承诺尚未反映在已报告的结果中。 在记录中,管理层提到了几个订单和承诺: - 英国国家医疗服务体系(NHS)的七台系统订单,这是公司历史上最大的订单,已在第四季度计入总订单。 - 一个美国多系统订单未在第三季度完成,但客户表示将在2017财年分批下单,第一台已进入积压订单。 - Radixact系统在多个参考站点安装,第一台已安装,但尚未全面商业发布。 - Onrad系统在中国获得批准,但预计订单活动在2017财年下半年。 这些是具体的订单或安装,但管理层是否将其作为“验证轨迹”的“新承诺”?NHS订单是已完成的订单,已计入结果。美国多系统订单是预期的,但尚未完全实现。Radixact参考站点是安装,不是财务承诺。Onrad是监管批准,不是承诺。 管理层没有提到内部人士购买股票、战略投资或合作伙伴资源投入。他们提到的是订单和安装,这些是常规业务活动,而非“知情方”的额外承诺。此外,管理层没有将这些描述为“验证轨迹”的证据,而是作为正常业务进展。 因此,答案应为NO。
← Back to the full ARAY analysis
Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management report that parties WITH DIRECT INSIDE KNOWLEDGE of the company's operations - such as existing major customers, strategic partners, insiders, or sophisticated investors who have completed due diligence - have RECENTLY made significant NEW financial or resource commitments to the company, in a way that management presents as validation of trajectory not yet visible in reported results? Answer YES only when management describes concrete recent commitments by informed parties (expanded contracts after initial experience, insider share purchases, strategic investment, partner resource dedication) AND frames these as evidence the business is inflecting beyond what current numbers show. Answer NO if commitments are routine renewals, hoped-for, or described only by analysts. Use only the supplied transcript. Answer only YES or NO.
Companies that answered YES
| Ticker | Company | Call | Date | Call grade |
| ROCK |
Gibraltar Industries, Inc. |
Q1 2024 |
2024-05-01 |
B+ |
| LTRX |
Lantronix, Inc. |
Q3 2024 |
2024-04-29 |
C |
| KOPN |
Kopin Corporation |
Q4 2023 |
2024-03-14 |
C+ |
| AIRG |
Airgain, Inc. |
Q3 2023 |
2023-11-09 |
F |
| NBTX |
Nanobiotix S.A. |
Q2 2023 |
2023-09-27 |
D |
| BZUN |
Baozun Inc. |
Q2 2023 |
2023-08-28 |
D |
| EVGO |
EVgo, Inc. |
Q2 2022 |
2022-08-09 |
C+ |
| SYM |
Symbotic Inc. |
Q3 2022 |
2022-08-01 |
B+ |
| GFS |
GLOBALFOUNDRIES Inc. |
Q3 2021 |
2021-11-30 |
A |
| LOB |
Live Oak Bancshares, Inc. |
Q3 2018 |
2018-10-25 |
C+ |
| PRIM |
Primoris Services Corporation |
Q2 2018 |
2018-08-11 |
C+ |
| PLAB |
Photronics, Inc. |
Q2 2017 |
2017-05-17 |
C+ |
| IONS |
Ionis Pharmaceuticals, Inc. |
Q1 2017 |
2017-05-09 |
C |
| WYY |
WidePoint Corporation |
Q3 2016 |
2016-11-09 |
D |
| GOGO |
Gogo Inc. |
Q1 2016 |
2016-05-06 |
C+ |
How the model reasoned
PRIM · Q2 2018 → YESThe question is: Does management report that parties WITH DIRECT INSIDE KNOWLEDGE of the company's operations - such as existing major customers, strategic partners, insiders, or sophisticated investo...YES The transcript shows management describing recent new awards to the T&D Group from major customers who were hesitant due to prior financial concerns about Willbros (now under Primoris). David King frames these as validation of the T&D trajectory, noting the work "outpaces anything he has seen in his 40-plus years" and that the MSA backlog reached its highest level at $1.1 billion, presented as evidence of inflection beyond the one-month Willbros results. He also references three such customers now placing awards post-due diligence on financial viability. This meets the criteria for informed parties (existing customers who completed due diligence) making significant new commitments framed as positive validation. The $145 million pipeline awards are also noted as a "really good start," though tied more to the acquisition than direct customer commitments. No insider share purchases or strategic investments are mentioned. The earn-out achievement by the Florida subsidiary is routine and not framed as new validation.
EVGO · Q2 2022 → YESThe question is: Does management report that parties WITH DIRECT INSIDE KNOWLEDGE of the company's operations - such as existing major customers, strategic partners, insiders, or sophisticated investo...NO The transcript describes the GM-Pilot partnership as a new eXtend agreement involving EVgo procuring, constructing, operating, and maintaining up to 2,000 stalls at up to 500 locations, with Cathy noting it exceeds IRR hurdles and provides capital-light growth. However, this is presented as management's own forward 2022 guidance and pipeline expansion rather than as external validation from informed parties (e.g., GM's resource dedication or insider commitments) proving an inflection beyond current Q2 results. The Delta supply agreement and Cadillac offer are also company-initiated, not framed as third-party validation of unshown trajectory. No insider purchases, strategic investments 3, or similar are mentioned. Thus, it does not meet the strict criteria. NO. The answer is NO. The question is specific: Does management report that parties WITH DIRECT INSIDE KNOWLEDGE... have RECENTLY made significant NEW financial or resource commitments...
AIRG · Q3 2023 → YESThe question is: Does management report that parties WITH DIRECT INSIDE KNOWLEDGE of the company's operations - such as existing major customers, strategic partners, insiders, or sophisticated investo...NO The transcript mentions several design wins and new partner additions, but these are not framed by management as concrete recent commitments from parties with direct inside knowledge that validate an inflection beyond current reported results. Instead, they are presented as part of the company's strategic pipeline and expected future shipments, without explicit language tying them to validation of 2024 trajectory separate from the weak Q3/Q4 guidance. The early purchase orders for Lantern FWA are noted, but the overall narrative emphasizes inventory overhang and delayed projects rather than recent commitments as proof of recovery. No insider purchases, strategic investments, or resource dedications by informed parties are described.
More from the question bank
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.